Analysen von Keyur Parekh
18.07.14 | GSK Neutral | Goldman Sachs Group Inc. | |
15.07.14 | MorphoSys Neutral | Goldman Sachs Group Inc. | |
15.07.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
05.06.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
14.05.14 | GSK Neutral | Goldman Sachs Group Inc. | |
13.05.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
16.04.14 | Novartis Neutral | Goldman Sachs Group Inc. | |
14.04.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
Werbung
|
|||
20.08.12 | Novartis neutral | Goldman Sachs Group Inc. | |
01.07.10 | AstraZeneca halten | Goldman Sachs Group Inc. |